PhotoMedex, Inc. (NASDAQ: PHMD) provides novel solutions designed for application in the areas of dermatology, therapeutic skin care and surgical products & services. The company is currently developing proprietary excimer laser and fiber-optic systems to treat dermatological applications such as psoriasis and vitiligo. PhotoMedex’s XTRAC® was the first FDA market-cleared excimer laser system designed to treat dermatological applications such as psoriasis and vitiligo. For further information, visit the Company’s web site at www.photomedex.com.
- 17 years ago
QualityStocks
PhotoMedex, Inc. (NASDAQ: PHMD)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – Adageis’ AI-Powered Platform Empowers Smarter Billing, Better Care
Adageis, a healthcare technology company, is transforming how providers manage insurance payments with its AI-driven…
-
QualityStocksNewsBreaks – Nightfood Holdings Inc. (NGTF) Positioning to Lead Future of Hospitality
Nightfood Holdings (OTCQB: NGTF) is rapidly expanding its footprint in the hospitality and hotel automation sectors…
-
QualityStocksNewsBreaks – Nicola Mining Inc. (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) Coverage Initiated with Outperform Rating, Target Set at C$0.70 / US$0.50
Nicola Mining (TSXV: NIM) (FSE: HLIA) (OTCQB: HUSIF) a junior exploration company with near-term cash…